Jinghua Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Jinghua Pharmaceutical Group has a total shareholder equity of CN¥2.9B and total debt of CN¥22.3M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥3.2B and CN¥326.3M respectively. Jinghua Pharmaceutical Group's EBIT is CN¥275.1M making its interest coverage ratio -735.4. It has cash and short-term investments of CN¥1.3B.
Key information
0.8%
Debt to equity ratio
CN¥22.31m
Debt
Interest coverage ratio | -735.4x |
Cash | CN¥1.26b |
Equity | CN¥2.89b |
Total liabilities | CN¥326.25m |
Total assets | CN¥3.21b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002349's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥307.3M).
Long Term Liabilities: 002349's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥19.0M).
Debt to Equity History and Analysis
Debt Level: 002349 has more cash than its total debt.
Reducing Debt: 002349's debt to equity ratio has reduced from 21.3% to 0.8% over the past 5 years.
Debt Coverage: 002349's debt is well covered by operating cash flow (1468.2%).
Interest Coverage: 002349 earns more interest than it pays, so coverage of interest payments is not a concern.